June
4th,2012 (health.com) A blood test that
measures a marker of immune-system activity may help doctors identify people who
are at risk of dying at an early age, a new study suggests.
Researchers at
the Mayo Clinic measured levels of the immune-system molecules known as free
light chains in 15,859 Minnesotans age 50 and up, and found that people whose
levels were in the top 10% were four times more likely than the other study
participants to die over the next 13 years.
Doctors commonly
test for free light chains to diagnose and manage blood disorders and
blood-related cancers, such as multiple myeloma or lymphoma. This study, which
was published this week in the journal Mayo Clinic Proceedings, is the first to
link high levels of free light chains with earlier death in a group of people
without any known blood disorders.
Normally, light chains bind with so-called heavy chains to form infection-fighting antibodies. The presence of unattached "free" light chains has long been recognized as a signal that the immune system has gone awry, either due to inflammation, infection, or both, says lead author Vincent Rajkumar, M.D., a hematologist at the Mayo Clinic, in Rochester, Minnesota.
Normally, light chains bind with so-called heavy chains to form infection-fighting antibodies. The presence of unattached "free" light chains has long been recognized as a signal that the immune system has gone awry, either due to inflammation, infection, or both, says lead author Vincent Rajkumar, M.D., a hematologist at the Mayo Clinic, in Rochester, Minnesota.
Health.com: How to live to
100
Elevated free
light chain levels have been observed in people with kidney dysfunction, and are
also seen in autoimmune disorders such as rheumatoid arthritis and lupus. Even
after the researchers took into account the kidney function, age and gender of
the participants, however, those with the highest free light chain levels were
still twice as likely as their peers to die during the
study.
Free
light chain levels appeared to be equally effective at predicting death from
many different causes, including cancer, heart disease, lung disease and
diabetes.
It's
not clear from the findings why, exactly, free light chains are linked to a
higher risk of early death. High levels could be a marker of inflammation, which
is associated with heart disease and numerous other health problems. But it's
also possible they're a sign of normal, age-related deterioration of the immune
system, the study notes.
Health.com: The
cholesterol-inflammation
connection
And
it's still unclear how this test might be useful in generally healthy people.
For now, Rajkumar and his colleagues urge doctors not to use the test as a
screening instrument, as that will simply serve to alarm
patients.
On
the other hand, Rajkumar says, if doctors order the test for a specific reason
and it comes back high, they may want to use that information to test for
additional problems that could then be treated.
"It
might be telling you something you might be missing," he
says.
Dr.
Neil Blumberg, a professor of pathology and laboratory medicine at the
University of Rochester Medical Center, in Rochester, New York, says he's
skeptical that free light chain tests are more powerful than existing tests that
measure immune-system function or markers of inflammation, such as C-reactive
protein.
Health.com: Do you really need that
medical test?
The
study authors didn't compare the free light chain test with these other tests,
Blumberg points out, and it "may not measure anything that we don't get with
white cell count or C-reactive protein or 15 other tests which are cheaper and
easier to do."
Besides, Blumberg
says, if a person's test results were to come back sky-high, the advice for
preventing an early death would likely be what patients hear from their doctors
already. "We really don't need any more tests to tell us we ought to lose
weight, exercise, [and] eat a less pro-inflammatory diet," he
says.